Construct: ORF ccsbBroadEn_14877
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF018969.1_s300c1, BRDN0000458265
- DNA Barcode:
- None
- Epitope Tag:
- None
- Notes:
- Early stop codon detected
Originally Annotated References:
- Gene:
- VRK2 (7444)
Vector Information:
- Vector Backbone:
- pDONR223
- Pol II Cassette 1:
- n/a
- Pol II Cassette 2:
- n/a
- Selection Marker:
- n/a
- Visible Reporter:
- n/a
- Epitope Tag:
- n/a
Current transcripts matched by this ORF:
| Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
|---|---|---|---|---|---|---|---|---|
| 1 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | NM_001130480.2 | 98.6% | 48.3% | (many diffs) |
| 2 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | NM_001130481.2 | 98.6% | 48.3% | (many diffs) |
| 3 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | NM_001288837.1 | 98.6% | 48.3% | (many diffs) |
| 4 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | NM_006296.6 | 98.6% | 48.3% | (many diffs) |
| 5 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | XM_005264540.4 | 98.6% | 48.3% | (many diffs) |
| 6 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | XM_011533092.3 | 98.6% | 48.3% | (many diffs) |
| 7 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | NM_001130482.2 | 94.2% | 43.8% | (many diffs) |
| 8 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | XM_006712090.4 | 76.6% | 61.8% | (many diffs) |
| 9 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | XM_017004858.2 | 76.6% | 61.8% | (many diffs) |
| 10 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | NM_001130483.2 | 76.5% | 61.9% | (many diffs) |
| 11 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | NM_001288838.1 | 76.5% | 61.9% | (many diffs) |
| 12 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | XM_006712091.4 | 76.5% | 61.9% | (many diffs) |
| 13 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | NM_001288836.1 | 75.6% | 25.1% | (many diffs) |
| 14 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | NM_001288839.1 | 75.6% | 25.1% | (many diffs) |
| 15 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | XM_006712092.4 | 75.6% | 25.1% | (many diffs) |
| 16 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | XM_006712093.4 | 75.6% | 25.1% | (many diffs) |
| 17 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | XM_017004859.2 | 75.6% | 25.1% | (many diffs) |
| 18 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | XM_017004860.2 | 75.6% | 25.1% | (many diffs) |
| 19 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | XM_017004861.2 | 75.6% | 25.1% | (many diffs) |
| 20 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | XM_017004862.2 | 75.6% | 25.1% | (many diffs) |
| 21 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | XM_017004863.2 | 75.6% | 25.1% | (many diffs) |
| 22 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | XM_017004865.1 | 53.4% | 32.2% | (many diffs) |
| 23 | human | 7444 | VRK2 | VRK serine/threonine kinase 2 | XM_017004866.1 | 53.4% | 32.2% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 95
- ORF end:
- 860
- ORF length:
- 765
- Sequence:
-
1 AATGATTTTA TTTTGACTGA TAGTGACCTG TTCGTTGCAA CAAATTGATG AGCAATGCTT 61 TTTTATAATG CCAACTTTGT ACAAAAAAGT TGGCATGCCA CCAAAAAGAA ATGAAAAATA 121 CAAACTTCCT ATTCCATTTC CAGAAGGCAA GGTTCTGGAT GATATGGAAG GCAATCAGTG 181 GGTACTGGGC AAGAAGATTG GCTCTGGAGG ATTTGGATTG ATATATTTAG CTTTCCCCAC 241 AAATAAACCA GAGAAAGATG CAAGACATGT AGTAAAAGTG GAATATCAAG AAAATGGCCC 301 GTTATTTTCA GAACTTAAAT TTTATCAGAG AGTTGCAAAA AAAGACTGTA TCAAAAAGTG 361 GATAGAACGC AAACAACTTG ATTATTTAGG AATTCCTCTG TTTTATGGAT CTGGTCTGAC 421 TGAATTCAAG GGAAGAAGTT ACAGATTTAT GGTAATGGAA AGACTAGGAA TAGATTTACA 481 GAAGATCTCA GGCCAGAATG GTACCTTTAA AAAGTCAACT GTCCTGCAAT TAGGTATCCG 541 AATGTTGGAT GTACTGGAAT ATATACATGA AAATGAATAT GTTCATGGTG ATATAAAAGC 601 AGCAAATCTA CTTTTGGGTT ACAAAAATCC AGACCAGGTT TATCTTGCAG ATTATGGACT 661 TTCCTACAGA TATTGTCCCA ATGGGAACCA CAAACAGTAT CAGGAAAATC CTAGAAAAGG 721 CCATAATGGG ACAATAGAGT TTACCAGCTT GGATGCCCAC AAGGGAGTAG CCTTGTCCAG 781 ACGAAGTGAC GTTGAGATCC TCGGCTACTG CATGCTGGGG GTGNNTGGGT GTGGGAAACT 841 TCCCTTGGGG AACAGAACCT GAAGGACCCC TGTGGCTGTG CAGACTGCTA AAAACAAATT 901 CTTGTTGGAC GAGCTCCCCC AGTCAGTGCT TAATNGGCTC CCTCTGGAAG CAGTGNCTGT 961 GAAATAGCCC AATTTTTGGT ATGTGCTCAT AGTTTAGCAT ATGATGAAAA GCCAAACTAT 1021 CAAGCCCTCA AGAAAATTTT GAACCCTCAT GGAATACCTT TAGGACCACT GGACTTTTCC 1081 ACAAAAGGAC AGAGTATAAA TGTCCATACT CCAAACAGTC AAAAAGTTGA TTCACAAAAG 1141 GCTGCAACAA AGCAAGTCAA CAAGGCACAC AATAGGTTAA TCGAAAAAAA AGTCCACAGT 1201 GAGAGAAGCG CTGAGTCCTG TGCAACATGG AAAGTGCAGA AAGAGGAGAA ACTGATTGGA 1261 TTGATGAACA ATGAAGCAGC TCAGGAAAGC ACAAGGAGAA GACAGAAATA TCAAGAGTCT 1321 CAAGAACCTT TGAATGAAGT AAACAGTTTC CCACAAAAAA TCAGCTATAC ACAATTCCCA 1381 AACTCATTTT ATGAGCCTCA TCAAGATTTT ACCAGTCCAG ATATATTCAA GAAGTCAAGA 1441 TCTCCATCTT GGTATAAATA CACTTCCACA GTCAGCACGG GGATCACAGA CTTAGAAAGT 1501 TCAACTGGAC TTTGGCCTAC AATTTCCCAG TTTACTCTTA GTGAAGAGAC AAACGCAGAT 1561 GTTTATTATT ATCGCATCAT CATACCTGTC CTTTTGATGT TAGTATTTCT TGCTTTATTT 1621 TTTCTCTTGC CAACTTTCTT GTACAAAGTT GGCATTATAA GAAAGCATTG CTTATCAATT 1681 TGTTGCAACG AACAGGTCAC TATCAGTCAA AATAAAATCA TTATTGCCAT CCAGGCTGAT 1741 TCCCCCC